KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Dividends payables (2016 - 2025)

Eli Lilly (LLY) has disclosed Dividends payables for 17 consecutive years, with $1.3 billion as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Dividends payables rose 14.93% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Jun 2025, up 14.93%, and an annual FY2024 reading of $1.3 billion, up 15.15% over the prior year.
  • Dividends payables was $1.3 billion for Q2 2025 at Eli Lilly, roughly flat from $1.3 billion in the prior quarter.
  • Across five years, Dividends payables topped out at $1.3 billion in Q4 2024 and bottomed at $770.8 million in Q2 2021.
  • Average Dividends payables over 5 years is $1.1 billion, with a median of $1.0 billion recorded in 2022.
  • The sharpest move saw Dividends payables increased 14.45% in 2022, then grew 15.19% in 2023.
  • Year by year, Dividends payables stood at $885.5 million in 2021, then grew by 14.87% to $1.0 billion in 2022, then increased by 14.94% to $1.2 billion in 2023, then grew by 15.15% to $1.3 billion in 2024, then dropped by 0.08% to $1.3 billion in 2025.
  • Business Quant data shows Dividends payables for LLY at $1.3 billion in Q2 2025, $1.3 billion in Q4 2024, and $1.2 billion in Q2 2024.